🇺🇸 FDA
Patent

US 10273274

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

granted A61KA61K31/495A61K38/00

Quick answer

US patent 10273274 (Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5) held by The Regents of the University of California expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/495, A61K38/00, A61K38/1709, A61P